Latest News

Researchers at the Whole Health Oncology Institute, in collaboration with the Chopra Foundation in the USA, have carried out a meta-analysis of thousands of studies devoted to medical cannabis. Their work reveals overwhelming scientific support for the potential of cannabis not only to relieve cancer-related symptoms, but also to slow, or even counteract, the progression of the disease itself.

According to a survey conducted by Abacus Data, 64% of Canadians want the federal government to take steps to better support the cannabis industry and secure its economic future.

Israel's Minister of Economy and Industry has announced that he would like to impose tariffs of up to 165% on Canadian cannabis for the next four years. However, this decision has not yet been approved by the Knesset Finance Committee and Minister of Finance.

Medical cannabis is more effective than prescription and over-the-counter sleeping pills in relieving sleep disorders, according to a survey of 1,000 patients. According to the survey results, nearly 70% of patients said that cannabis was a better sleep aid than prescription sleeping pills, and over 90% said that medical cannabis was more effective than over-the-counter sleeping pills.

A study led by the University of Sydney, one of the world's largest longitudinal clinical trials of medical cannabis, has demonstrated clinically significant improvements in the quality of life of patients and those suffering from chronic illnesses.

The proportion of young people aged 12-18 who have used cannabis is at its lowest in 25 years, according to a McCreary Society survey of British Columbian youth, dropping from 25% in 2018 to 22% in 2023.

The French Ministry of Health has confirmed that it has notified the European Commission of three regulatory texts defining the framework for the production and authorization of cannabis for medical use, and has ratified the extension of the current experiment until March 31, 2026.

The Japanese parliament has passed a law authorizing cannabis-based medicines. However, the government took advantage of this legislative reform to toughen penalties against recreational cannabis.

Ohio becomes the 24th U.S. state to legalize cannabis, which means that 53% of the country's population now has access to cannabis. However, it remains illegal at federal level.

In the face of today's challenges, Canadian producers are increasingly looking to exporting their cannabis. In fact, according to Health Canada, cannabis exports are set to increase significantly in 2023-2023, with over a thousand applications already submitted.

The first report of the Expert Panel on the Legalization of Cannabis has been published and is now available.

A monograph on cannabis flower will be included in the European Pharmacopoeia. "This will have no legal impact in Canada, but will be very important for export to Europe (...) It is a list of tests that must be carried out on the product and acceptable limits that must be applied," explains Hubert Marceau of PhytoChemia Laboratories.